Carson Wealth (CWM LLC)’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
AIM
VCM
NAMA
Carson Wealth (CWM LLC)'s PACB Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Pacific Biosciences (PACB) stake by 767% in Q1 2026, buying an estimated $85.1K and bringing the position to 53,794 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #3537.
Carson Wealth (CWM LLC) first reported a position in PACB in Q4 2021 and has held it in 16 quarters since. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.
- Carson Wealth (CWM LLC) held 53,794 shares of Pacific Biosciences worth $71K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 47,591 Pacific Biosciences shares in Q1 2026, an estimated $85.1K.
- Pacific Biosciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3537 holding.
- Carson Wealth (CWM LLC) first reported a position in Pacific Biosciences in Q4 2021 and has held it in 16 quarters since.
- 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.